A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

The efficacy and safety of efinaconazole 10% solution is acceptable among older adults with onychomycosis and comparable to the general population.

Clay W. Walker, MPAS, PA-C, is an assistant professor of family medicine at the Mayo Clinic in Phoenix, Arizona. He has over 8 years of experience in primary care, internal medicine, and ...

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.

A survey of more than 20,000 patients revealed a lack of trust in information about cancer, whether it comes from scientists, ...

Prademagene zamikeracel, a gene-modified treatment applied surgically, was seen to increase wound healing and pain in RDEB.

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Young patients with atopic dermatitis prioritize different treatment goals and have varying preferences from their caregivers.

[A]lthough our findings found that there is insufficient evidence to suggest that dupilumab use is associated with joint pain, the prevalence of joint pain observed among patients treated with ...

Neoadjuvant cobolimab and dostarlimab followed by surgery and adjuvant dostarlimab may confer benefits over perioperative pembrolizumab in patients with high-risk, resectable melanoma.

The leading causes of readmission among patients who received THA included sepsis (14.6%), nonseptic infections (14.8%), ...

Patients with ID receiving TNF inhibitors are at greater risk for cutaneous malignancy than patients who are biologic-naïve.